| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |